Skip to content
healthcare.dev

TAZAROTENE

NDC 0713-0805, tazarotene, gel, from Cosette Pharmaceuticals, Inc..

Product NDC
0713-0805
Status
Listed
Labeler
Cosette Pharmaceuticals, Inc.
Dosage form
GEL
Route
TOPICAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA215433
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0713-0805 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TAZAROTENE.5 mg/g

Pharmacologic classes

Retinoid [EPC]; Retinoids [CS]

Package NDCNDC-11Package
0713-0805-31007130805311 TUBE in 1 CARTON (0713-0805-31) / 30 g in 1 TUBE
0713-0805-99007130805991 TUBE in 1 CARTON (0713-0805-99) / 100 g in 1 TUBE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ecd718fd-c06e-4b3a-8aca-fa51e7c51a66
  • NADAC price for package 00713080531

    GET /v1/drugs/nadac/00713080531

Use it

Look up 0713-0805 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0713-0805 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0713-0805. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.